Analyst Research: NovaBay Pharmaceuticals Inc (NBY)

NBY on American Stock Exchange

1.25USD
23 May 2013
Price Change (% chg)

$-0.09 (-6.34%)
Prev Close
$1.34
Open
$1.32
Day's High
$1.33
Day's Low
$1.23
Volume
226,043
Avg. Vol
197,143
52-wk High
$1.76
52-wk Low
$0.90

Search Stocks
Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - NOVABAY PHARMACEUTICALS, INC. (NBY-A) 6:41am EDT Thomson Reuters Stock Report 11 25.00
ValuEngine Detailed Valuation Report for NBY 22 May 2013 ValuEngine, Inc. 11 127.00
NovaBay Pharmaceuticals, Inc. (NBY) - Pharmaceuticals & Healthcare - Deals and Alliances Profile 22 May 2013 GlobalData 40 250.00
NOVABAY PHARMACEUTICALS INC (NBY) 12-months forecast 17 May 2013 Pechala's Reports 1 15.00
Novabay Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 17 May 2013 Reuters Investment Profile 12 20.00
NOVABAY PHARMAC (NBY) Zacks Company Snapshot 14 May 2013 Zacks Investment Research Inc. 1 12.00
TheStreet.com Ratings Stock Report For: NOVABAY PHARMACEUTICALS INC 11 May 2013 TheStreet.com Ratings 5 10.00
 

People

Name Age Since Current Position

Ramin Najafi

 53 2004 Chairman of the Board, President, Chief Executive Officer

Thomas Paulson

 65 2008 Chief Financial Officer, Treasurer, Secretary

Keith Bley

 2013 Senior Vice President - Product Development

David Stroman

 67 2011 Senior Vice President - Ophthalmic Product Development

Roy Wu

 58 2009 Senior Vice President - Business & Corporate Development
» More People

NovaBay Pharmaceuticals Inc News

» More NBY News
Search Stocks